Ziprasidone monotherapy in bipolar II depression: an open trial.

[1]  T. Suppes,et al.  Bipolar II disorder: arguments for and against a distinct diagnostic entity. , 2008, Bipolar Disorders.

[2]  M. Thase,et al.  Aripiprazole Monotherapy in Nonpsychotic Bipolar I Depression: Results of 2 Randomized, Placebo-Controlled Studies , 2008, Journal of clinical psychopharmacology.

[3]  David J Miklowitz,et al.  Effectiveness of adjunctive antidepressant treatment for bipolar depression. , 2007, The New England journal of medicine.

[4]  Franco Benazzi,et al.  Bipolar disorder—focus on bipolar II disorder and mixed depression , 2007, The Lancet.

[5]  J. Calabrese,et al.  A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. , 2005, The American journal of psychiatry.

[6]  S. Kapur,et al.  A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone. , 2004, The American journal of psychiatry.

[7]  J. Calabrese,et al.  Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. , 2003, Archives of general psychiatry.

[8]  H. Möller,et al.  Recent advances in the treatment of bipolar depression , 2007 .

[9]  J. Ballenger A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression , 2007 .

[10]  L. Scott,et al.  Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. , 2006, CNS drugs.